Clinical Trials List
Protocol NumberCYBBV1302
2014-07-01 - 2016-06-30
Phase III
Terminated3
-
Trial Applicant
Chuang Yi Biotech
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- WEI-SHIUNG YANG Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hua-Shui Hsu Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Ching Yang Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
200 participants
